Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT04070443
Previous Study | Return to List | Next Study

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (TIPI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04070443
Recruitment Status : Recruiting
First Posted : August 28, 2019
Last Update Posted : December 10, 2021
Information provided by (Responsible Party):
Centre Leon Berard

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2029
Estimated Study Completion Date : June 1, 2029